COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,778 Articles (22,946 medRxiv, 8,832 bioRxiv)

Most recent first Previous |  Page 436: Articles 4351-4360  | Next

Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line
Mamatis, J. E., Gallardo-Flores, C. E., Walsh, T., Sangwan, U., Colpitts, C. C.
10.1101/2023.07.20.549884 — Posted: 2023-07-20
Design of SARS-CoV-2 protease inhibitors with improved affinity and reduced sensitivity to mutations
Westberg, M., Su, Y., Zou, X., Huang, P., Rustagi, A., Garhyan, J., Patel, P. B., Fernandez, D., Wu, Y., Ning, L., Beck, A., Karim, M., Hao, C., Saenkham-Huntsinger, P., Tat, V., Drelich, A., Peng, B.-H., Einav, S., Tseng, C.-T. K., Blish, C., Lin, M. Z.
10.1101/2023.07.19.549739 — Posted: 2023-07-20
Epigenetic Age Acceleration in Surviving versus Deceased COVID-19 Patients with Acute Respiratory Distress Syndrome following Hospitalization
Bejaoui, Y., Humaira Amanullah, F., Saad, M., Taleb, S., Bradic, M., Megarbane, A., Ait Hssain, A., Abi Khalil, C., El Hajj, N.
10.1101/2023.07.18.549478 — Posted: 2023-07-19
Intranasal lavage with hypochlorous acid safely reduces the symptoms in the ambulatory patient with COVID-19.
Abner, M. L.
10.1101/2023.07.17.23292426 — Posted: 2023-07-18
Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
Liu, Y., Yong, X., Liu, J., Zeng, Y., Nie, J., Cui, X., Wang, T., Wang, Y., Chen, Y., Kang, W., Yang, Z.
10.1101/2023.07.17.23292762 — Posted: 2023-07-18
Identification of predictive patient characteristics for assessing the probability of COVID-19 in-hospital mortality
Rajwa, B., Naved, M. M. A., Adibuzzaman, M., Grama, A. Y., Khan, B. A., Dundar, M., Rochet, J.-C.
10.1101/2023.07.16.23292738 — Posted: 2023-07-18
Evaluation of the impact of COVID-19 pandemic on hospital admission related to common infections
Fahmi, A., Palin, V., Zhong, X., Yang, Y.-T., Watts, S., Ashcroft, D. M., Goldacre, B., Mackenna, B., Fisher, L., Massey, J., Mehrkar, A., Bacon, S., the OpenSAFELY collaborative, , Hand, K., van Staa, T.
10.1101/2023.07.16.23292723 — Posted: 2023-07-18
The scientific chaos phase of the Great Pandemic: A longitudinal analysis and systematic review of the first surge of clinical research concerning COVID-19
Adami, T., Ries, M.
10.1101/2023.07.14.23292667 — Posted: 2023-07-18
Identification of COVID-19 Vaccine-Hesitancy Predictors in the United States
Saldarriaga, E. M.
10.1101/2023.07.17.23292772 — Posted: 2023-07-18
Effects of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines
Zhang, X., Han, X., Chen, B., Fu, X., Gong, Y., Yang, W., CHEN, Q.
10.1101/2023.07.16.23292747 — Posted: 2023-07-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).